Amgen To Invest $200M In Singapore Facility

Thousand Oaks-based biotech giant Amgen said this week that it is planning to build a new manufacturing facility in Singapore, and will invest approximately $200M in the new plant. Amgen said the new facility will be located in the Tuas Biomedical Park area of Singapore, and will go towards its manufacturing capability for monoclonal antibodies. Amgen also revealed that it will start construction in the next few months.